• IMA sites
  • IMAJ services
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Mon, 22.12.25

REVIEWS

IMAJ | volume 27

Journal 12, December 2025
pages: 806-812

Hyperbaric Oxygen Therapy for Cerebral Arterial Air Embolism Secondary to Transbronchial Lung Biopsies: More Air than Substance?

1 Pulmonary Institute, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel 2 Department of Neurology, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel 3 Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel 4 National Hemophilia Center and Thrombosis and Hemostasis Institute, Sheba Medical Center, Tel Hashomer, Israel

Summary

Cerebral arterial air embolism (CAAE) is a rare, but often fatal, complication of interventional bronchoscopy. Despite its rarity, a high index of suspicion can facilitate early diagnosis and prompt treatment. Standard of care treatment for CAAE is hyperbaric oxygen therapy, despite limited definitive data supporting its efficacy, given the conceptual potential for reversibility of neurological impairment. We describe five cases from our institution, and review the clinical presentation, pathophysiology, diagnosis, and management of suspected CAAE. Based on published case reports involving transbronchial lung biopsies (TBLB), standard of care treatment for CAAE secondary to TBLB is hyperbaric oxygen therapy, although its efficacy in this context has not been unambiguously validated in clinical practice.

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel